Subscribe to Job Alert
Join our happy subscribers
ALIMA’S SPIRIT: ALIMA’s purpose is to save lives and provide care for the most vulnerable populations, without any discrimination based on identity, religion or politics, through actions based on proximity, innovation, and the alliance of organizations and individuals. We act with humanity and impartiality in accordance with universal medical ethics. To gain access to patients, we undertake to act in a neutral and independent manner.
Our CHARTER defines the VALUES and PRINCIPLES of our action:
Putting the Patient First
Revolutionizing humanitarian medicine
Responsibility and freedom
Improve the quality of our actions
Placing trust
Collective intelligence
ALIMA promotes and defends the principles of fundamental human rights. ALIMA has a zero-tolerance approach towards those guilty of acts of gender and sexual violence as well as towards inaction in the face of alleged or proven acts of violence. The protection of those benefiting from and impacted by our intervention is our top priority in everything we do. Everyone collaborating with ALIMA is committed to:
Respect the charter, the code of conduct, the institutional policies including the policy of protection against abuse of power and sexist and sexual violence, the policy of prevention of corruption and fraud;
Report any violation of the policies, framework documents and procedures to a superior, to a referent or to alert@alima.ngo
CARING - INNOVATING - TOGETHER:
Since its creation in 2009, ALIMA has treated more than 4 million patients and today deploys its operations in 11 African countries. In 2018 we developed 41 humanitarian medical response projects to meet the needs of populations affected by conflicts, epidemics and extreme poverty. All of these projects are carried out in support to national authorities through nearly 330 health facilities (including 28 hospitals and 300 health facilities). Whenever possible We work in partnership with local NGO's to ensure that our patients benefit from the best and most relevant expertise wherever it is, whether within their own country or in the rest of the world. In addition, to improve the humanitarian response, we are carrying out operational and clinical research projects particularly in the field of the fight against malnutrition and viral haemorrhagic fevers
ALIMA’S TEAM: more than 2000 people are currently working for ALIMA. The field teams, closest to the patients, receive their support from coordination teams generally based in the countries’ capitals. These receive support from the 4 desk teams and the emergency and opening team based at the operational headquarters in Dakar, Senegal. The Paris and New York teams are actively working to raise funds and represent ALIMA. The rest of the ALIMA Galaxy includes individuals and partner teams working on behalf of other organizations such as medical NGOs BEFEN, ALERT Health, SOS Doctors / KEOOGO, AMCP, research organizations PACCI and INSERM, Bordeaux or Copenhagen Universities, the INGO Solidarités International and many others.
COUNTRIES WHERE WE WORK: Mali, Burkina Faso, Central African Republic, Nigeria, Niger, Chad, Democratic Republic of Congo, Cameroon, Guinea, South Sudan, Mauritania.
THE WORK WE DO COVERS: Malnutrition, Maternal Health, Primary Health, Pediatrics, Malaria, Epidemics (Ebola, Cholera, Measles, Dengue, Lassa Fever), Hospitalization, Emergencies, Gender Based Violence, Opening / Closing.
BACKGROUND
Lassa fever (LF) is an acute viral illness (epidemic prone disease) that can result in a viral hemorrhagic fever (VHF) syndrome. The causative agent is the Lassa virus, which is primarily transmitted by rodents. The illness was first reported in Borno State, Nigeria in 1969. Since then cases and outbreaks continue to be reported in Nigeria with a seasonal resurgence during the dry season (December to May) and the diseases is increasingly recognized to be endemic in many other parts of West Africa.
Treatment includes the antiviral drug ribavirin since the 1980s and supportive care. However, there is relatively little scientific information on the disease and its treatment, and there is a significant need for research data. There is currently no vaccine available. Lassa fever is considered by WHO as apriority disease for urgent research and development.
In addition to prevention and case management from ALIMA, the CORAL platform created by ALIMA, PACCI programm (Côte d’Ivoire) and Inserm (France) have set up the LASCOPE cohort.
LASCOPE is an observational cohort study of Lassa fever clinical Course and Prognostic factors in an Epidemic context in Nigeria. It aims to describe the characteristics of inpatients admitted for a suspected diagnosis of Lassa fever in tertiary hospitals situated in the most affected Nigerian states since 2018. Its primary objective being to depict the clinical, biological course, management and outcomes of hospitalized patients with a diagnosis of confirmed Lassa fever. The study takes place within the Infection Control and Research Center (ICRC) in the Federal Medical Center in Owo (FMCO), Ondo State, Nigeria.
As well as LASCOPE, ALIMA, through CORAL, ALIMA aims to develop and set up others phase II and III clinical trials projects.
POST TYPOLOGY – FUNCTIONNAL AND HIERARCHICAL RELATIONSHP
Mission Location:
Clinical Research Assistant
Mission Location: Nigeria, Ondo State, Owo
Project: Clinical research and research cohort
Management lines:
S/he will work in collaboration with:
MISSION AND MAIN ACTIVITIES
Mission and Objectives
S/he will perform the following tasks:
Contribute to the implementation and smooth running of the study:
Ensure the monitoring of the study:
Participate in teamwork:
Share with the International project manager and the International CRA information related to the study follow-up
Implementation of prevention measures against abuse of power, gender-based and sexual violence:
EXPERIENCE AND SKILLS
Educational and experience:
Other qualities:
Check how your CV aligns with this job
Submit online your Cover letter, CV with colour picture and qualifications with contact details all in the same files, to ALIMA’s recruitment email recruitment@nigeria.alima.ngo Subject: Clinical Research Assistant - Owo
Last day for Submission of application 1st August 2022
Applications are processed in the order of arrival and we reserve the right to close the offer before the term initially indicated if a good application is successful. Only full applications will be taken into account. Only accepted applications will be contacted.
Female candidates are strongly encouraged to apply.
Important remarks
Only successful applicants will be called for interview.
No monetary transactions, neither demands of favours in kind, nor other types of favouritism will be tolerated in the recruitment process.
Build your CV for free. Download in different templates.
Join our happy subscribers